tecentriq hybreza

Generic: atezolizumab and hyaluronidase-tqjs

Labeler: genentech, inc.
NDC Directory HUMAN PRESCRIPTION DRUG BLA Inactive Finished

Drug Facts

Product Profile

Brand Name tecentriq hybreza
Generic Name atezolizumab and hyaluronidase-tqjs
Labeler genentech, inc.
Dosage Form INJECTION
Routes
SUBCUTANEOUS
Active Ingredients

atezolizumab 1875 mg/15mL, hyaluronidase (human recombinant) 30000 U/15mL

Manufacturer
Genentech, Inc.

Identifiers & Regulatory

Product NDC 50242-933
Product ID 50242-933_9bc7ee05-8ccb-489b-94a9-eb317f72324e
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category BLA
Application Number BLA761347
Listing Expiration 2026-12-31
Marketing Start 2024-09-12

Pharmacologic Class

Established (EPC)
programmed death receptor-1 blocking antibody [epc] endoglycosidase [epc]
Mechanism of Action
programmed death receptor-1-directed antibody interactions [moa]
Chemical Structure
antibodies, monoclonal, humanized [cs] antibodies, monoclonal [cs] antibodies [cs] glycoside hydrolases [cs]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 50242933
Hyphenated Format 50242-933

Supplemental Identifiers

RxCUI
2693892 2693899
UNII
52CMI0WC3Y 743QUY4VD8
NUI
N0000191260 N0000191259 M0556300 M0001357 M0001352 N0000175531 M0009499

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name tecentriq hybreza (source: ndc)
Generic Name atezolizumab and hyaluronidase-tqjs (source: ndc)
Application Number BLA761347 (source: ndc)
Routes
SUBCUTANEOUS
source: ndc

Resolved Composition

Strengths
  • 1875 mg/15mL
  • 30000 U/15mL
source: ndc
Packaging
  • 1 VIAL, SINGLE-DOSE in 1 BOX (50242-933-01) / 15 mL in 1 VIAL, SINGLE-DOSE
  • 1 VIAL, SINGLE-DOSE in 1 BOX (50242-933-86) / 15 mL in 1 VIAL, SINGLE-DOSE
source: ndc

Packages (2)

50242-933-01 1 VIAL, SINGLE-DOSE in 1 BOX (50242-933-01) / 15 mL in 1 VIAL, SINGLE-DOSE 50242-933-86 1 VIAL, SINGLE-DOSE in 1 BOX (50242-933-86) / 15 mL in 1 VIAL, SINGLE-DOSE

Ingredients (2)

atezolizumab (1875 mg/15mL) hyaluronidase (human recombinant) (30000 U/15mL)

Linked Drug Pages (1)

Tecentriq Hybreza ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["SUBCUTANEOUS"], "spl_id": "9bc7ee05-8ccb-489b-94a9-eb317f72324e", "openfda": {"nui": ["N0000191260", "N0000191259", "M0556300", "M0001357", "M0001352", "N0000175531", "M0009499"], "unii": ["52CMI0WC3Y", "743QUY4VD8"], "rxcui": ["2693892", "2693899"], "spl_set_id": ["a617b089-ce66-464b-987b-b45d029b4d6f"], "pharm_class_cs": ["Antibodies, Monoclonal, Humanized [CS]", "Antibodies, Monoclonal [CS]", "Antibodies [CS]", "Glycoside Hydrolases [CS]"], "pharm_class_epc": ["Programmed Death Receptor-1 Blocking Antibody [EPC]", "Endoglycosidase [EPC]"], "pharm_class_moa": ["Programmed Death Receptor-1-directed Antibody Interactions [MoA]"], "manufacturer_name": ["Genentech, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 BOX (50242-933-01)  / 15 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "50242-933-01", "marketing_start_date": "20240912"}, {"sample": true, "description": "1 VIAL, SINGLE-DOSE in 1 BOX (50242-933-86)  / 15 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "50242-933-86", "marketing_start_date": "20240912"}], "brand_name": "Tecentriq Hybreza", "product_id": "50242-933_9bc7ee05-8ccb-489b-94a9-eb317f72324e", "dosage_form": "INJECTION", "pharm_class": ["Antibodies [CS]", "Antibodies", "Monoclonal [CS]", "Antibodies", "Monoclonal", "Humanized [CS]", "Endoglycosidase [EPC]", "Glycoside Hydrolases [CS]", "Programmed Death Receptor-1 Blocking Antibody [EPC]", "Programmed Death Receptor-1-directed Antibody Interactions [MoA]"], "product_ndc": "50242-933", "generic_name": "atezolizumab and hyaluronidase-tqjs", "labeler_name": "Genentech, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Tecentriq Hybreza", "active_ingredients": [{"name": "ATEZOLIZUMAB", "strength": "1875 mg/15mL"}, {"name": "HYALURONIDASE (HUMAN RECOMBINANT)", "strength": "30000 U/15mL"}], "application_number": "BLA761347", "marketing_category": "BLA", "marketing_start_date": "20240912", "listing_expiration_date": "20261231"}